NEW YORK – SimBioSys announced Monday that UT Southwestern will help improve the company's PhenoScope tumor visualization and analysis platform.
Under the collaboration, the terms of which were not disclosed, the lab of Isaac Chan, assistant professor of internal medicine and molecular biology, will provide transcriptomic data and bioinformatics expertise to help expand PhenoScope's tumor bank.
The platform, for which SimBioSys won a $2 million Small Business Innovation Research grant from the National Institutes of Health last year, combines genomic, cellular, microscopic tissue environment, and other biological data with clinical outcomes to construct spatially resolved tumor models.
"SimBioSys' PhenoScope platform exposes the intricacies of the tumor microenvironment through its multi-modal data integration and spatial biophysical analysis capabilities, unveiling new insights to help accelerate more individualized drug development," Chan said in a statement.
The Chicago-based company also raised $15 million in a Series A funding round in 2021 to develop and commercialize TumorScope, a clinical decision-support platform for predicting how a patient's tumor will respond to different drugs, and of which PhenoScope is one part.